window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 22, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Editor’s Choice

  • Opinion & Events

    Beyond the band-aid: Brixton Biosciences’ drug-free revolution in pain management

    In the midst of an opioid crisis and growing frustration [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    myTomorrows tops 15,000 global patient matches for pre-approval treatment access

    Clinical trial platform’s AI and navigator-led model bridges gap in [...]

    May 5, 2026
  • Clinical & Regulatory

    Orforglipron: Lilly’s first oral GLP 1 pill cuts A1C by up to 1.6% and trims 16 lbs in Phase 3 trial

    May 5, 2026
  • Digital & Data

    ICU level care not definitive indicator for sepsis, new study shows

    May 5, 2026
  • Clinical & Regulatory

    AI appetite slows as clinical trial leaders refocus on risk-based strategies

    May 5, 2026
Previous23

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Lifebit awarded three-year NIHR BioResource research environment contract
    Categories: Biotech & Pharma Business, Digital & Data, Research & Development
  • Resolution Therapeutics partners with Blood Centers of America for RTX001 programme
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics
  • Researchers develop human iPS cell model of heart failure
    Categories: Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top